Skip to main content

Want a detailed portfolio tracker?

Evoke Pharma (EVOK) Revenue (2012 - 2025)

Evoke Pharma (EVOK) revenue from Sep 30, 2012 to Sep 30, 2025. The TTM Evoke Pharma (EVOK) revenue is $14M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Evoke Pharma (EVOK) Revenue CAGR table

PeriodCAGR
1 Year TTM+67.29%
3 Years TTM+90.98%

Annual Revenue change of Evoke Pharma (EVOK)

YearRevenueChange
2025$11M+8.39%
2024$10M+97.88%
2023$5.18M+106.37%
2022$2.51M+54.94%
2021$1.62M+8000.00%
2020$20KN/A
2019$0N/A
2018$0N/A
2017$0N/A
2016$0N/A
2015$0N/A
2014$0N/A
2013$0N/A
2012$0N/A
2011$0N/A
2010$0N/A
2009$0N/A
2008$0N/A
2007$0N/A